CONCORDBIO Quarterly Results, Profit & Loss, Balance Sheet (CONCORDBIO)

CONCORDBIO quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • CONCORDBIO Financials
  • CONCORDBIO Shareholding Pattern
  • CONCORDBIO Earnings Documents
  • CONCORDBIO Announcements
  • CONCORDBIO Corporate Actions
  • CONCORDBIO Bulk, Block & Insider Deals
  • CONCORDBIO Delivery Data
  • CONCORDBIO Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Concord Biotech Ltd (CONCORDBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Concord Biotech Ltd reported sales of ₹309 Cr, operating profit of ₹104 Cr (OPM 34%) and net profit of ₹70 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

CONCORDBIO quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales244430204247278326257309
Expenses146241143159179208175205
Operating Profit9818961889811882104
OPM40%44%30%36%35%36%32%34%
Other Income17915167151410
Interest00000000
Depreciation1315181819201818
Profit before tax1011845986861147895
Tax25%24%25%26%26%22%26%27%
Net Profit76140446364885870
EPS in Rs7.2613.424.216.086.168.495.596.75
CONCORDBIO profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7138531,0171,2001,0551,170
Expenses443509585694687768
Operating Profit270344432506368403
OPM38%40%42%42%35%34%
Other Income233737445246
Interest653110
Depreciation505454547475
Profit before tax238322413495345374
Tax26%25%25%25%25%-
Net Profit175240308372259279
EPS in Rs16.7222.9529.4535.5224.9426.99
Dividend Payout3%30%30%25%30%-
CONCORDBIO balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital1010101010
Reserves1,5161,8021,8172,0072,065
Borrowings103222
Other Liabilities164219194212249
Total Liabilities1,7012,0342,0232,2322,327
Fixed Assets575795795789771
CWIP211517479112
Investments246335353491533
Other Assets668854802873911
Total Assets1,7012,0342,0232,2322,327
CONCORDBIO cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity207246265245267
Cash from Investing Activity-112-158-155-160-143
Cash from Financing Activity-100-85-99-99-113
Net Cash Flow-4312-1411
Free Cash Flow52101180134172
CFO/OP99%92%85%70%100%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit99928570100
CONCORDBIO ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days119117125159159
Inventory Days434430331286485
Days Payable185190150135151
Cash Conversion Cycle368357306310493
Working Capital Days161152166193230
ROCE21%26%28%28%17%
  • CONCORDBIO Shareholding Pattern
  • CONCORDBIO Earnings Concalls
  • CONCORDBIO Growth Catalysts
  • CONCORDBIO Corporate Actions
  • CONCORDBIO Announcements
  • CONCORDBIO Results & Documents
  • CONCORDBIO Bulk & Block Deals
  • CONCORDBIO Delivery Data